The HDAC inhibitor LBH589 could rapidly promote PD-L1 expression by increasing histone acetylation of the PD-L1 promoter region in human and mouse melanoma cells [24], which reveals the involvement of histone acetylation modifications in PD-L1 expression. The gene discussed is HDAC9; the disease is melanoma.